Calumet, Inc. (NASDAQ:CLMT – Get Free Report) has received an average rating of “Hold” from the eight analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $20.0417.
A number of equities research analysts recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 22nd. Wall Street Zen downgraded shares of Calumet from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. Zacks Research raised Calumet from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. The Goldman Sachs Group raised their price target on Calumet from $15.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, HC Wainwright reiterated a “buy” rating and issued a $33.00 price objective on shares of Calumet in a report on Monday, November 10th.
Check Out Our Latest Analysis on CLMT
Institutional Investors Weigh In On Calumet
Calumet Price Performance
Shares of NASDAQ:CLMT opened at $19.69 on Friday. Calumet has a 1 year low of $7.68 and a 1 year high of $23.75. The business’s 50-day moving average is $19.43 and its 200-day moving average is $17.62. The company has a market capitalization of $1.71 billion, a price-to-earnings ratio of -45.79 and a beta of 1.18.
Calumet (NASDAQ:CLMT – Get Free Report) last posted its quarterly earnings results on Friday, November 7th. The oil and gas company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.09. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.06 billion. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same period in the previous year, the business posted ($1.18) EPS. Analysts anticipate that Calumet will post -3.02 EPS for the current year.
Calumet Company Profile
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Further Reading
- Five stocks we like better than Calumet
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
